Role for nitric oxide in the development of the ferret retinogeniculate projection by Angelucci, Alessandra & Cramer, K S
The Journal of Neuroscience, December 15, 1996, 76(24):7995-8004
A Role for Nitric Oxide in the Development of the Ferret 
Retinogeniculate Projection
Karina S. C ram er , 1 A lessan d ra  A ngelucci , 1 Jo n g -O n  H ahm ,2 Mikhail B. B ogdanov ,3 an d  M riganka S u r1
1 Department o f Brain and Cognitive Sciences, M assachusetts Institute o f Technology, Cambridge, M assachusetts 
02139, 2Department o f Neurosurgery, Georgetown University Medical Center, Washington, DC 20007, and 3Department 
o f Neurology, M assachusetts General Hospital, Boston, M assachusetts 02114
The ferret retinogeniculate projection segregates into eye- 
specific layers during the first postnatal week and into ON/OFF 
sublaminae, which receive inputs from either on-center or off- 
center retinal ganglion cells, during the third and fourth post­
natal weeks. The restriction of retinogeniculate axon arbors into 
eye-specific layers appears to depend on action potential ac­
tivity (Shatz and Stryker, 1988) but does not require activation 
of NMDA receptors (Smetters et al., 1994). The formation of 
ON/OFF sublaminae is also activity-dependent and is disrupted 
by in vivo blockade of NMDA receptors (Hahm et al., 1991). To 
investigate a possible mechanism whereby blockade of 
postsynaptic NMDA receptors in the lateral geniculate nucleus 
(LGN) results in changes in the size and position of presynaptic 
axon arbors, we tested the role of the diffusible messenger 
nitric oxide (NO) in the development of the retinogeniculate 
pathway. We found previously that NO synthase (NOS) is tran­
siently expressed in LGN cells during the refinement of retino­
geniculate projections (Cramer et al., 1995). In this study, treat­
ment with NG-nitro-L-arginine (L-NoArg), an arginine analog that
inhibits NOS, during the third and fourth postnatal weeks re­
sulted in an overall pattern of sublamination that was signifi­
cantly reduced compared with normal and control animals. 
Single retinogeniculate axon arbors were located in the middle 
of eye-specific layers rather than toward the inner or outer half 
as in normal or control animals. The effect of NOS inhibition was 
not a consequence of the hypertensive effect of L-NoArg. In 
contrast to the effect of L-NoArg on the formation of ON/OFF 
sublaminae, treatment with L-NoArg during the first postnatal 
week did not disrupt the formation of eye-specific layers. Bio­
chemical assays indicated significant inhibition of NOS during 
both treatment periods. These data suggest that NO acts to­
gether with NMDA receptors in activity-dependent refinement 
of connections during a specific phase of retinogeniculate 
development.
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T he precise p a tte rn  of connections underlying adult visual p ro ­
cessing in m am m als arises from  the refinem ent o f less specific 
connectivity p resen t early in developm ent. T he m echanism s by 
which diffuse connections are refined rely a t least in p a rt on 
neuronal activity. In  the ferret, retinogeniculate connections are 
refined in two distinct phases. D uring the first postnata l week, 
re tinal axons within the la tera l geniculate nucleus (L G N ) segre­
gate into eye-specific layers (L inden e t al., 1981). D uring the th ird  
and fourth  postnatal weeks, afferents to  the A  and A1 layers, 
which receive input from  the con tralateral and ipsilateral eye, 
respectively, fu rther segregate into sublam inae. T he inner sub­
lam ina receives inputs from  on-cen ter retinal ganglion cells, 
w hereas the ou ter sublam ina receives inputs from  off-center re t­
inal ganglion cells (Stryker and Z ahs, 1983; H ahm  and Sur, 1988). 
B lockade of afferent activity with tetrodotoxin  disrupts the fo rm a­
tion of eye-specific layers in the cat retinogeniculate projection 
(Shatz and Stryker, 1988) and the form ation o f O N /O FF  sublami-
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nae in the fe rre t (C ram er and Sur, 1996). T he form ation of 
O N /O FF  sublam inae requires N M D A  recep to r activation (H ahm  
e t al., 1991) during the th ird  postnatal week, w hereas the fo rm a­
tion o f eye-specific layers during the first postnata l w eek does no t 
(Sm etters e t al., 1994). T he sequential segregation of retino- 
geniculate afferents into eye-specific layers in an N M D A  receptor- 
independen t m anner and into O N /O FF  sublayers in an N M D A  
recep to r-dependen t m anner provides an opportun ity  to  investi­
gate how neuronal activity effects changes in synaptic connections 
in the L G N  and how activity may be transduced  via different 
biochem ical pathways during different phases of developm ent.
In  retinofugal developm ent, the re  is strong evidence th a t pre- 
synaptic modifications result from  changes in postsynaptic activity. 
Postsynaptic N M D A  receptors contribute significantly to  retino- 
geniculate synaptic transm ission (Sillito e t al., 1990; Kwon e t al., 
1991; E sguerra  e t al., 1992; R am oa and M cCorm ick, 1994). 
N M D A  recep to r antagonists infused into the fe rre t L G N  disrupt 
the p a tte rn  o f sublam ination of presynaptic retinogeniculate ax­
ons; re tinal ganglion cell axon arbors are e ither abnorm ally large 
o r are restric ted  in size bu t term inate  in inappropria te  locations 
w ithin the L G N  (H ahm  e t al., 1991). In rats, blockade of N M D A  
receptors in the superio r colliculus leads to  abnorm al branching of 
retinocollicular axons (Simon e t al., 1992). In  the frog re tino tectal 
system, application o f N M D A  to the tectum  reduces the b ranch­
ing o f re tina l axon arbors and the num ber o f re tino tectal synapses 
(Cline and C onstantine-Paton, 1990; Y en e t al., 1995). Thus,
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postsynaptic activity in ta rget structures significantly influences 
the structure and contacts o f presynaptic re tina l axons, suggesting 
a role for a retrog rade  m essenger. N itric oxide (N O ) has been 
p roposed  as a diffusible re trog rade  m essenger in the m aintenance 
o f h ippocam pal long-term  po ten tia tion  (LTP) (B ohm e e t al., 
1991; O ’D ell e t al., 1991; Schum an and M adison, 1991; H aley et 
al., 1992; cf. G ribkoff and Lum -R agan, 1992) and, by analogy, in 
activity-dependent refinem ent o f connections in the visual p a th ­
way during developm ent (M ontague e t al., 1991; W u e t al., 1994; 
C ram er and Sur, 1995).
Because N O  synthase (N OS), the synthetic enzyme for N O , 
requires C a2+  (for review, see G arthw aite, 1991; B red t and 
Snyder, 1992; V incent and H ope, 1992), N O  may be produced  as 
a consequence o f C a2+  influx through N M D A  receptors. NOS 
activity, which can be revealed using N A D P H -d iap h o rase  h isto­
chem istry (Dawson e t al., 1991; H ope e t al., 1991), is develop­
m entally regulated  in the fe rre t L G N  (C ram er e t al., 1995). N O  is 
thus at its highest levels in postsynaptic cells during sublam inar 
refinem ent. In the p resen t study, we have assessed the role o f N O  
in the form ation o f both  eye-specific layers and O N /O FF  sublam i­
nae in the fe rre t retinogeniculate pathway. W e find th a t N O  has 
a role in the la tte r process o f O N /O FF  sublam ination, which also 
involves N M D A  receptors, bu t no t in the earlie r form ation of 
eye-specific layers, which does no t involve N M D A  receptors.
M A T E R IA L S  A N D  M E T H O D S
ON/OFF sublamination. Two separate methods were used to study the 
role of NO in the formation of the overall pattern of ON/OFF sublami­
nae. First, ferret kits received daily intraperitoneal injections of L-NoArg 
in three doses: low (0.04 mg/kg/d), intermediate (0.4 mg/kg/d), and high 
(4-40 mg/kg/d). Control animals received NG-nitro-D-arginine methyl 
ester (d-NAME) (40 mg/kg/d) or L-NoArg + L-Arginine (40 mg/kg/d of 
each) daily starting at postnatal day 14 (P14) and continuing through P26. 
Normal controls received no intraperitoneal injections. On P24, animals 
were given atropine (3 mg/kg, s.c.) and anesthetized with ketamine 
(30-40 mg/kg, i.m.). The left eyelid was opened, and an intravitreal 
injection of 5-10 ^l of 4-5%  WGA-HRP in distilled water was made into 
the left eye. At P26, animals were given an overdose of sodium pento­
barbital (>100 mg/kg, i.p.) and perfused intracardially with 0.9% saline 
followed by 4% paraformaldehyde for 5-10 min. Brains were removed, 
equilibrated in 30% sucrose in 0.1 m phosphate buffer, pH 7.4, containing 
up to 0.5% paraformaldehyde, and sectioned at 50 fxm in the horizontal 
plane using a freezing microtome. Sections were processed using tetra- 
methylbenzidine (TMB) to reveal HRP histochemically (Mesulam, 1978).
In a second set of experiments, L-NoArg was administered focally over 
the LGN via osmotic minipumps. P14 ferrets were anesthetized with 
ketamine (40 mg/kg) and diazepam (0.3 to 0.5 mg/kg, i.p.) or midazolam 
(0.3 to 0.5 mg/kg, i.m.) and also given atropine (3 mg/kg). An incision was 
made in the scalp, and an osmotic minipump (Alzet model 2002) con­
taining saline or L-NoArg (0.5 mM) was inserted underneath the skin on 
the back of the neck. The minipump was connected to a 22 gauge cannula. 
A small hole was made in the cranium with a 26 gauge needle, and the 
cannula was inserted through the hole from the dorsal surface through 
the cortex and above the thalamus, slightly anterior to the LGN, with the 
tip of the cannula in close proximity to the LGN. Areas connected to the 
LGN were posterior to the point of entry of the cannula; it is thus unlikely 
that connected areas were affected by drug treatment, and the issue of 
mechanical or surgical damage was addressed directly in control experi­
ments using saline minipumps. The cannula was glued in place and 
covered with dental acrylic, and the wound was sutured. Animals were 
treated with antibiotics prophylactically during the survival period (until 
P26). Intraocular injections, histology, and analysis were performed as in 
animals receiving intraperitoneal injections. The cannulae were tested to 
ensure that there were no blockages. Alternate sections were processed 
for Nissl substance to assess the placement of the cannulae.
To assess sublamination, each section through the LGN was given a 
score on a scale from 0 to 3, based on the proportion of the labeled A 
layer that contained a pale staining region between inner and outer 
sublaminae. This assessment was done objectively by a “blind” observer, 
who did not know which treatment group the sections belonged to. A
single score for each animal was obtained from the mean of all scored 
sections.
Assessment o f blood pressure effects. We measured blood pressure in 
normal animals during the fourth postnatal week and in age-matched 
animals treated daily from P14 with L-NoArg (40 mg/kg, i.p.). Animals 
were anesthetized with 0.5 mg/kg midazolam intramuscularly and 50 
mg/kg ketamine intramuscularly. The left carotid artery was exposed and 
cannulated with a 24 gauge catheter attached by saline-filled tubing to a 
Gould P23 pressure transducer. Blood pressure measurements were 
displayed digitally on a Gould SP1405 pressure monitor. Measurements 
were noted every 30 sec for up to 20 min. Animals were then killed with 
sodium pentobarbital (>100 mg/kg, i.p.).
To determine whether changes in blood pressure account for the effect 
of L-NoArg on sublamination, we administered 40 mg/kg/d, i.p., L-NoArg 
together with verapamil (5 mg/kg/d, i.p.), an antihypertensive calcium 
channel blocker, from P14 to P26. Preliminary acute experiments sug­
gested that this dose of verapamil reversed the pressor effects of L-NoArg. 
An injection of WGA-HRP was made in the left eye at P24, and blood 
pressure measurements were made immediately before perfusion on P26. 
Tissue was processed and analyzed as described above.
Effects o f NOS blockade on individual axon arbors. Sublamination of 
retinogeniculate afferents was assessed at the level of individual retinal 
ganglion cell axon arbors in animals treated systemically with 40 mg/kg/d 
L-NoArg or 40 mg/kg/d d-NAME from P14 to P21. Axon labeling and 
analysis of axon arbors were done at P21 according to the methods 
outlined in Hahm et al. (1991), so that the effects of NOS blockade could 
be compared with the effects of NMDA receptor blockade. Ferrets were 
given an overdose (>100 mg/kg, i.p.) of sodium pentobarbital and were 
perfused transcardially with chilled, oxygenated (95% O2/5% CO2) arti­
ficial ACSF containing (in mM): 126 NaCl, 3 KCl, 1.25 NaH2PO4, 10 
dextrose, 20 NaHCO3, 1.2 MgSO4, 2.5 CaCl2, pH 7.4. The brain was 
removed quickly and placed in chilled ACSF. The cortices were removed, 
and the diencephalon was hemisected. The pia mater overlying the optic 
tract was removed, and two or three small deposits of HRP were made in 
the optic tract overlying the ventral portion of the LGN using pulled glass 
pipettes coated with concentrated HRP. Diencephalon halves were 
placed in an aquarium containing ACSF and continuously perfused with 
95% O2/5% CO2 at room temperature for 3-5 hr to allow transport of 
HRP. The tissue was then immersion-fixed in 2% paraformaldehyde/1% 
glutaraldehyde overnight, allowed to equilibrate in 30% sucrose in 0.1 m 
phosphate buffer, and sectioned in the horizontal plane at 100 fxm. 
Sections were processed using diaminobenzidine (DAB) histochemistry 
with cobalt chloride enhancement (Adams, 1981). Briefly, sections were 
incubated in 0.1 m Tris buffer, pH 7.4, for 5 min; transferred to 1% CoCl2 
in Tris buffer for 20 min; rinsed in Tris buffer; transferred to 0.1 m 
phosphate buffer, pH 7.4; and incubated in DAB (0.03% in phosphate 
buffer) alone for 20 min and then with 0.03% H2O2 for 20 min. Sections 
were rinsed in several changes of phosphate buffer, dehydrated through a 
graded series of alcohols, cleared in Histoclear, and coverslipped.
Axon arbors that were well filled and clearly distinguishable from other 
axons were reconstructed using a camera lucida with a 63 X oil immersion 
objective. The area of arbors was determined for the polygon formed by 
the outer branches of the arbor using a drawing tablet with a Neuron 
Tracing System (Eutectic Electronics). For each section, a line was drawn 
bisecting the A layer. The sublamination index (Hahm et al., 1991) was 
determined for each axon as the proportion of the axon arbor area in the 
half of the A layer containing the majority of that arbor; the sublamina­
tion index thus varied from 0.5 (no sublamination) to 1 (complete 
sublamination).
Eye-specific layers. To study the effect of NOS blockade on the forma­
tion of eye-specific layers, animals received intraperitoneal injections of 
L-NoArg, 20 mg/kg/d, from P1 to P7. This dose was at least as effective at 
increasing brain [arginine]/[citrulline] as the dose that significantly dis­
rupted ON/OFF sublamination at a later age (see Results). Control 
animals received d-NAME (20 mg/kg/d); normal, untreated animals were 
also included in the study. At P7, animals were anesthetized with hypo­
thermia, and both eyelids were opened. The left eye was injected with 5 
^l of 5% WGA-HRP (Sigma, St. Louis, MO) in saline or distilled water; 
the right eye was injected with 5 ^l of 1% cholera toxin B (CTB) subunit 
(List Biological Labs, Campbell, CA) in distilled water. At P8, animals 
received an overdose of barbiturate anesthesia and were perfused intra- 
cardially with 0.9% saline followed by 4% paraformaldehyde. After 
equilibration in 30% sucrose in 0.1 m phosphate buffer, brains were 
sectioned in the horizontal plane at 40 or 50 fxm.
One series of sections was used to reveal HRP using TMB, and the
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series of adjacent sections was used to reveal CTB, using the method 
described by Angelucci et al. (1996). Briefly, sections were washed in 
PBS, pH 7.4, rinsed in methanol and 0.3% hydrogen peroxide to quench 
endogenous and injected peroxidase activity, treated with 0.1 M glycine, 
preincubated in 2-8%  normal rabbit serum (NRS, Vector Laboratories, 
Burlingame, CA) and 2.5% bovine serum albumin (BSA), then incubated 
in goat anti-CTB primary antibody (List) at a concentration of 1:4000 for 
1-2 d at room temperature in a solution containing 2% NRS, 2.5% BSA, 
and 2% Triton X-100. The primary antibody was rinsed, and the sections 
were incubated in a solution containing biotinylated rabbit anti-goat 
antibodies (Vector Laboratories), 2% NRS, 2.5% BSA, and 1% Triton 
X-100. The Vector ABC kit was used to label the antigen-antibody 
complex with HRP, together with DAB or the Vector VIP substrate to 
visualize HRP. Sections were dehydrated in a graded series of alcohol, 
cleared in Histoclear, and coverslipped.
Camera lucida drawings were made of TMB-stained and CTB-stained 
material, and drawings of adjacent sections were superimposed to assess 
the degree of segregation according to the eye of origin. Because tissue 
stained with the two methods had slightly different extents of shrinkage, 
the magnification was adjusted to bring adjacent sections in register, using 
the lateral edges of the nucleus.
A1
Figure 1. Horizontal sections through the LGN of P26 ferrets after 
intraocular injections of WGA-HRP in the contralateral eye, viewed with 
bright-field microscopy. A, Normal ferret LGN. The dark arrow in the 
contralateral projection to layer A shows a pale staining region between 
on and off sublaminae. For simplicity, C layers are not labeled in the 
micrographs. B, LGN from an animal treated with the high dose of 
L-NoArg between P14 and P26. A pale staining region between sublami­
nae is not evident. C, LGN from a control animal treated with L-NoArg 
together with L-Arg. A pale staining intersublaminar zone is visible. In 
A - C, the A  and A1 layers are indicated. The inner (A i) and outer (A o ) 
sublaminae are labeled in A  and C where they are visible. Scale bars 




Figure 2. Summary of sublamination scores (with SEM) for all experi­
ments in this study. Numbers in parentheses indicate the number of 
animals in each treatment group. Higher scores signify greater sublami­
nation. Sublamination scores decreased with increasing doses of L-NoArg. 
The highest dose of systemically applied L-NoArg produced a significant 
reduction in sublamination compared with normal. Systemic treatment 
with L-NoArg together with verapamil (Ver) to reverse the pressor effect of 
L-NoArg resulted in disrupted sublamination. Control animals treated 
with D-NAME or L-NoArg together with L-arginine (L-Arg) showed no 
effect. Focal application of L-NoArg using surgically implanted osmotic 
minipumps also reduced sublamination, whereas minipumps containing 
saline had no effect.
HPLC measurements o f [arginine] and [citrulline]. To assess the effec­
tiveness of systemic administration of L-NoArg in the inhibition of brain 
NOS activity, we injected two animals daily from P14 to P28 with 
L-NoArg (40 mg/kg, i.p.) and two animals daily from P1 to P8. These 
animals and three control littermates in each age group were perfused 
with sterile saline, and the brains were homogenized in 1N perchloric acid 
buffer. Because NOS produces citrulline from arginine during NO syn­
thesis, we used the ratio [arginine]/[citrulline] as an indicator of NOS 
activity. Citrulline and arginine concentrations were detected by HPLC 
with electrochemical detection after precolumn derivatization with 
o-phtalaldehyde, essentially as described previously for glutamate (Bog­
danov and Wurtman, 1994). Amino acid derivates were separated on a 3 
am C18 ODS 80 X 4.6 mm column and detected using an ESA 5200A 
coulometric detector with an ESA 5014 dual-electrode analytical cell. The 
first electrode was set at +200 mV and the second at +400mV. The 
mobile phase delivered at 1.2 ml/min was 0.1 M sodium dibasic phosphate 
buffer, 25% methanol, and 5% acetonitrile, pH 6.4. Standards of arginine 
and citrulline at known concentrations were also run. The concentration 
of these amino acids was determined using the area under the peak 
corresponding to the elution time of the standards.
R E S U L T S
In  the first p a rt o f this study, we exam ined the ro le o f N O  in the 
segregation o f O N /O FF  sublam inae. O ne group o f anim als re ­
ceived daily, systemic injections o f L-NoArg, a N OS inhibitor, 
from  P14 to  P26. T rea tm en t w ith a high dose o f L-NoArg (4 -4 0  
m g/kg/d) d isrupted  form ation o f sublam inae. Sublam ination in 
norm al anim als is clearly visible in horizontal sections through the 
LG N , w hereas in trea ted  anim als, clearly delineated  sublam inae 
a re  no t evident (Fig. 1A ,B ). A  sublam ination score was assigned 
to  each section o f th e  L G N  containing visible A  and A1 layers. 
T he score ranged from  0 to  3, based  on the fraction o f the A  layer 
clearly divided by a pale  staining in tersublam inar zone th a t ap-
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proxim ately bisected the A  layer longitudinally; e.g., a score o f 1 
indicated th a t one-th ird  o f the A  layer contained a pale staining 
in tersublam inar zone. T he score for each anim al was ob tained  by 
averaging the scores from  each section. O n average, 10 sections 
w ere scored through each LGN . T he scored sections spanned the 
depth of the L G N  containing both A  and A1 layers. W e found no 
systematic differences in sublam ination scores at different depths 
w ithin the LGN . Sublam ination scores from  anim als in all condi­
tions are sum m arized in Figure 2. T he m ean sublam ination score 
(±  SEM ) for anim als trea ted  w ith the high dose o f L-NoArg was 
0.24 ±  0.13 (n =  6). This value was significantly less than  th a t seen 
in norm al anim als, 2.1 ±  0.24 (n = 6; p  <  0.001, S tuden t’s t test). 
In  addition, trea ted  anim als had  significantly lower sublam ination 
scores than  two contro l groups. O ne contro l group (n =  3) 
received 40 mg/kg/d L-NoArg together w ith 40 mg/kg/d L-arginine, 
the norm al substrate for the N OS binding site. In  these animals 
(Fig. 1C), the m ean sublam ination score was 1.96 ±  0.18, which 
was significantly higher than  scores from  L-N oA rg-treated anim als 
( p  <  0.0001). Because addition o f excess L-arginine can overcom e 
the effects o f N O S blockade, this contro l supports the assum ption 
th a t L-NoArg is acting on N OS (G arthw aite, 1991). A no ther 
contro l group (n =  3) received 40 mg/kg/d o f d-N A M E, an 
inactive enantiom er. T he sublam ination score o f this group was
B
Figure 3. Horizontal sections through the LGN of P26 ferrets after 
labeling with WGA-HRP in the contralateral eye. A, LGN treated with 
focal application of 0.5 mM L-NoArg from P14 to P26 via an implanted 
cannula attached to an osmotic minipump. The staining is uniform, and no 
pale staining in the intersublaminar zone is evident. B , Control LGN after 
implantation of a cannula attached to an osmotic minipump containing 
0.9% saline. As in Figure 1, the arrow indicates the intersublaminar zone, 
and the A and A1 layers and sublaminae Ai and Ao are labeled. Scale bars 
(shown in B): 200 fxm.
c
A1j
Figure 4. Horizontal sections through the LGNs of P26 ferrets ipsilateral 
to an intraocular WGA-HRP injection. A, A normal, untreated animal; 
sublamination is evident in the ipsilateral A1 layer, and sublaminae (A1i 
and A1o) are evident. The arrow indicates the intersublaminar zone. B, An 
animal treated with L-NoArg systemically. Sublamination is disrupted in 
the ipsilateral projection. C , An animal in which the contralateral LGN 
was treated with focal application of L-NoArg. Sublamination is evident 
(A1i and A1o), and the intersublaminar zone is indicated by the arrow. The 
effects of L-NoArg are thus restricted to the infused side after minipump 
implantation.
1.65 ±  0.37, which was also significantly h igher than  th a t o f the 
high dose L-NoArg group (p  <  0.01).
T o exam ine the dose-dependence o f the effect o f L-NoArg on 
sublam ination, an additional group o f anim als received in te rm e­
diate (0.4 mg/kg/d; n = 2) o r low (0.04 mg/kg/d; n = 2) doses of 
L-NoArg (Fig. 2). T he in term ediate-dose group had  a sublam ina­
tion score (±  SEM ) o f 1.04 ±  0.4, and the low-dose group had  a 
sublam ination score o f 1.5 ±  0.05. W hen data  from  all animals 
receiving systemic injections of L-NoArg w ere exam ined using a 
linear regression o f the sublam ination score versus the logarithm  
o f the dose, a significant correlation  was found (r =  0.87, p  <  
0.01). Thus, there  is a dose-dependent inhibitory effect o f system- 
ically applied L-NoArg on retinogeniculate sublam ination.
A nim als receiving in traperitoneal injections w ere m onitored, 
and their overall growth was com pared w ith th a t o f norm al ani-
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Figure 5. Camera lucida tracings of individual retinogeniculate axon arbors reconstructed after labeling with HRP. A, Four representative arbors from 
animals treated with 40 mg/kg/d L-NoArg from P14 to P21. The borders of the A layer are shown as bold lines above and below each axon arbor; the dashed 
line bisects these borders and represents an approximation of the sublaminar boundary. The axon arbors in this treatment group extend into both inner 
and outer sublaminae. B, Four representative arbors from animals treated with 40 mg/kg/d of the inactive isomer d-NAME. These axon arbors tend to 
be restricted to one-half of the A layer, corresponding to one sublamina. Scale bars (shown in B): 100 am.
mals. A nim als receiving high doses of L-NoArg appeared  healthy 
and gained as m uch w eight (as a fraction of their w eight before 
trea tm en t) as anim als receiving low doses and anim als receiving 
D-NAME. A nim als approxim ately doubled their weights betw een 
P14 and P26. O verall brain  m orphology appeared  norm al in all 
animals.
A lthough in traperitoneal application of L-NoArg dem onstrably 
reduces N O S activity in the brain  (see below ), it rem ains possible 
tha t the reduction  of sublam ination in the L G N  results second­
arily from  systemic or indirect effects of the drug ra ther than  from  
a direct effect on NOS in L G N  cells. Because N O  is a vasodilator, 
one possible systemic effect of L-NoArg is hypertension. W e 
addressed this possibility by m easuring m ean  arteria l blood p res­
sure directly during the fourth  postnatal w eek in four anim als 
trea ted  from  P14 w ith daily injections of 40 mg/kg L-NoArg and in 
four norm al, age-m atched controls. T he norm al m ean arterial 
blood pressure (±  SEM ) was 57.6 ±  4.6 m m Hg, and the m ean 
arteria l blood pressure in the group trea ted  w ith L-NoArg was 
83.1 ±  4.8 m m Hg. T he m ean  arteria l blood pressure increased 
significantly after the trea tm en t period (p  <  0.01, S tuden t’s t test).
W e then  trea ted  five anim als from  P14 to P26 w ith 40 mg/kg/d 
L-NoArg together w ith 5 mg/kg/d verapam il to counteract the 
hypertensive effect of L-NoArg. T he m ean arteria l b lood pressure 
in this group was 60.0 ±  1.63 m m Hg, which did no t differ from  
tha t of norm al anim als (p  >  0.6). W e assessed sublam ination in 
anim als trea ted  w ith L-NoArg together w ith verapam il. T he m ean 
sublam ination score in these anim als was 0.07 ±  0.03, which was 
significantly less than  scores from  norm al anim als (p  <  0.001) and 
did no t differ from  scores from  anim als trea ted  w ith L-NoArg 
alone ( p  = 0.28). The effects of NOS blockade on sublam ination 
are thus unlikely to result from  changes in m ean arteria l blood 
pressure.
To address the possibility tha t o ther indirect effects of system- 
ically applied L-NoArg underlie the observed disruption of sub­
lam ination, we applied L-NoArg (0.5 mM) directly over the LG N  
betw een P14 and P26 in six anim als using surgically im planted 
osm otic m inipum ps th a t re leased 0.5 a l  of solution per hour. In 
these anim als (Fig. 3A), sublam ination was disrupted  to an extent 
similar to tha t seen w ith systemic application (sublam ination 
score =  0.17 ±  0.07; p  <  0.001 com paring trea ted  and norm al
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anim als). A nim als trea ted  w ith contro l m inipum ps containing 
only saline (Fig. 3B) had a m ean sublam ination score of 1.80 ±  
0.25 (n =  3); this score was significantly g rea ter than  th a t obtained 
from  anim als trea ted  focally w ith L-NoArg (p  <  0.001) and did 
no t differ from  scores obtained from  norm al anim als ( p  =  0.5). 
Nissl staining confirm ed tha t the cannulae w ere correctly posi­
tioned  above the LG N . B ecause the m inipum ps delivered small 
regulated  am ounts of L-NoArg to the L G N  (we estim ate th a t the 
entire L G N  has a uniform  steady-state concentration  of the drug), 
these results support the view tha t the effect of L-NoArg on 
sublam ination results from  a reduction  of N O  in the LGN. In  
anim als trea ted  w ith L-NoArg through  osm otic m inipum ps, the 
disruptive effect on sublam ination was restricted  to  the infused 
side, w hereas sublam ination in the opposite LG N  appeared  n o r­
m al (Fig. 4), confirm ing the local natu re  of the effect of NOS 
blockade.
The p a tte rn  of sublam ination seen after W G A -H R P  eye injec­
tion results from  the labeling of m ost or all retinal ganglion axons 
from  the eye, and the pale  staining in tersublam inar region ap ­
pears to  result in norm al anim als from  the relatively sparse 
term ination  of axon arbors w ithin tha t zone (H ahm  e t al., 1991). 
W e sought to  determ ine how blockade of NOS affects individual 
axon arbors term inating  within the LGN. A xon arbors w ere re ­
constructed  in four anim als trea ted  w ith 40 mg/kg/d L-NoArg from  
P14 to  P21 and th ree  contro l anim als trea ted  w ith 40 mg/kg/d 
D-NAME. T hree to  four axons w ere draw n from  each brain; 
reconstructions w ere m ade w ithout knowledge of the trea tm en t 
group from  which the tissue was taken. F ou rteen  axons w ere 
drawn from  the L-N oA rg-treated group, and 11 axons w ere drawn 
from  the D -N A M E-treated group (Fig. 5). T he m ean sublam ina­
tion index for the L-NoArg group was 0.7 ±  0.04 (SEM ), and the 
m ean sublam ination index for the D-NAM E group was 0.94 ±  
0.03. This difference was statistically significant ( p  <  0.0001, 
S tudent's t test) and rem ained  significant w hen sublam ination 
indices from  axons of the sam e brain  w ere pooled  together so tha t 
each anim al was considered a single datum  (p  <  0.01); L-NoArg- 
trea ted  anim als in this case had a m ean sublam ination index of 
0.7 ±  0.03; D -N A M E-treated anim als had a sublam ination index 
of 0.94 ±  0.02. Sublam ination indices for L-N oA rg-treated ani­
mals in the p resen t study w ere similar to  those found for D-APV- 
trea ted  anim als in the study by H ahm  e t al. (1991); similarly, the 
sublam ination indices for D -N A M E-treated anim als w ere similar 
to  those found for norm al anim als (Fig. 6). A s w ith D-APV 
trea tm en t (H ahm  et al., 1991), axons trea ted  w ith L-NoArg were 
abnorm ally large and/or positioned incorrectly in the intersub- 
lam inar zone (Fig. 5), consistent w ith the in terp re ta tion  tha t NOS 
blockade and N M D A  receptor blockade inhibit sublam ination in 
a similar way.
W e then  exam ined the effect of NOS blockade on the form ation 
of eye-specific layers during the first postnatal week. In  this pa rt of 
the study, it was necessary to  use only systemic application of NOS 
inhibitors, because neonata l anim als are too  small to  accom m o­
date an im planted  cannula and osm otic m inipum p. A nim als w ere 
trea ted  from  P1 to  P7 with 20 mg/kg/d L-NoArg (n =  7) or 20 
mg/kg/d of the the control drug d-N A M E  (n =  1), or w ere left 
un trea ted  as norm al controls (n =  4). T he dose of L-NoArg used 
effectively d isrupted  sublam ination (see above) and had an inhib­
itory effect on brain  NOS (see below). W e exam ined the L G N  of 
these anim als at P8, after an terograde labeling of retinogeniculate 
projections at P7 w ith in traocular injection of W G A -H R P  in one 
eye and CTB subunit in the o ther eye. A lternate  sections w ere 
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Figure 6. Histogram summarizing the sublamination indices at P21 in 
normal animals and animals treated with drugs from P14 to P21. The 
sublamination index denotes the fraction of the total arbor area in the half 
of the layer containing the majority of that arbor. The two bars on the left 
(normal animals and animals treated with the NMDA receptor blocker 
d-APV) are data taken from Hahm et al. (1991); error bars indicate SEM. 
NOS blockade with L-NoArg and NMDA receptor blockade with d-APV 
result in a similar reduction of the sublamination index, whereas treatment 
with the control drug D-NAME does not reduce the sublamination index.
(M esulam , 1978) or im m unohistochem istry to  visualize CTB (A n­
gelucci e t al., 1996). Segregation of inputs from  the two eyes was 
evident in every case. T he staining patterns of left and right eye 
projections to  the two LG N s within a single brain  w ere com ple­
m entary  in sections stained using e ither TM B (Fig. 7) or CTB 
im m unohistochem istry. M oreover, w ithin each LG N , the staining 
pa tte rn  of TM B was com plem entary to  tha t of CTB and together, 
these labeled the full extent of the L G N  (Fig. 8). T reated  anim als 
did no t differ from  contro l anim als in weight; anim als in bo th  
groups increased their w eight by 240%  during the first postnatal 
week. O verall b rain  m orphology appeared  similar in norm al and 
trea ted  animals.
W e assessed the effectiveness of systemically applied L-NoArg 
on NOS activity in the brain  during the period  of eye-specific layer 
form ation as well as during the period  of O N /O FF sublam ination. 
In traperitonea l application of L-NoArg inhibits NOS activity in 
the brains of adult rats (Dwyer et al., 1991); our experim ents 
extend this result to  young ferrets. To assess NOS activity, we used 
H PL C  to  m easure the relative concentrations of arginine and 
citrulline in b rain  hom ogenates of trea ted  and norm al animals. 
C itrulline is p roduced  from  arginine by NOS stoichiom etrically 
along w ith N O; although there  are o ther sources and sinks for 
bo th  arginine and citrulline, the only pathw ay by which arginine is 
converted to  citrulline in the brain  is via NOS (O hta  e t al., 1994). 
T he [arginine]/[citrulline] ra tio  is thus a m eaningful m easure of 
NOS activity. In  our m aterial, the [arginine]/[citrulline] ra tio  for 
anim als trea ted  w ith 40 mg/kg/d L-NoArg from  P14 to  P28 (n =  2) 
was 1.0 ±  0.02, and the ratio  for norm al, age-m atched anim als 
(n =  3) was 0.57 ±  0.26. T reatm en t w ith L-NoArg thus increased 
the [arginine]/[citrulline] ra tio  by a factor of 1.75. W hen anim als 
received 20 mg/kg/d L-NoArg from  P1 to  P8 (n =  2), the [argi- 
nine]/[citrulline] ratio  was 3.0 ±  0.73, w hereas norm al, age- 
m atched controls (n =  3) had a ratio  of 1.1 ±  0.23 (Fig. 9). A t this 
age, trea tm en t w ith L-NoArg increased the [arginine]/[citrulline] 
ra tio  by a factor of 2.8. A cross ages, L-NoArg trea tm en t resulted  
in a significantly increased [arginine]/[citrulline] ra tio  com pared 
w ith norm al brains (p  <  0.02, two-way A N O V A  w ith drug tre a t­
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Figure 7. Horizontal sections through the LGNs of P8 
animals after anterograde labeling of retinogeniculate 
projections using intraocular injections of WGA-HRP 
in the left eye. A , B, Sections from the left (A ) and right 
(B) LGNs of a normal P8 ferret. C, D, Sections through 
the left (C) and right (D) LGNs of a ferret treated with 
20 mg/kg/d L-NoArg from P1 to P8. In A-D, the open 
arrows indicate the ipsilateral projection zone, or layer 
A1. The left and right LGNs show a complementary 
pattern of labeling in both normal and drug-treated 
animals. Scale bars (shown in C): 200 fxm.
m ent and age as two factors). T he ratio  was higher a t P8 com ­
pared  w ith P28 (p  <  0.02), possibly reflecting the relatively lower 
N OS activity at early ages (C ram er e t al., 1995). T he effectiveness 
o f the drug at P8 versus P28 (the  interactive effect o f drug 
trea tm en t and age) appeared  to be sim ilar (p  = 0.08). C hanges in 
[citrulline] are also a useful m easure o f N OS activity. In  our P28 
m aterial, L-NoArg trea tm en t reduced  [citrulline] to  86%  o f n o r­
m al levels, and in ou r P8 m aterial, L-NoArg trea tm en t reduced 
[citrulline] to  60% o f norm al levels. These decreases in [citrulline] 
are sim ilar to  those found by O hta  e t al. (1994) in extracellular 
dialysates o f adult ra t brain after trea tm en t with L-NoArg, and are 
consistent w ith the findings we ob tained  using [arginine]/[citrul- 
line]. These m easurem ents indicate th a t systemic application of 
L-NoArg significantly reduces N OS activity in the brain during 
both developm ental periods.
D IS C U S S IO N
T aken together, o u r results support a role for N O  in retinogenicu- 
late developm ent specifically during the period  of O N /O FF  sub­
lam ination w hen N M D A  recep to r activation is also requ ired  and 
w hen N A D P H -d iap h o rase  levels are high in L G N  cells. A lthough 
N A D P H -d iap h o rase  staining is developm entally regu lated  in 
L G N  cells, staining is p resen t in the neuropil in the L G N  a t all 
ages (C ram er e t al., 1995). N europil staining arises from  cholin­
ergic brainstem  projections (Bickford e t al., 1993). Because block­
ade o f N OS a t early ages does no t in terfere  with the form ation of 
eye-specific layers, it is unlikely th a t N O  produced  in the neuropil
is involved in early retinogeniculate p a tte rn  form ation. A  devel­
opm ental role for N O  has also been found in the chick retinotec- 
tal pathw ay, where N OS expression is highest during the rem oval 
o f a transien t ipsilateral projection (W illiams e t al., 1994) and 
blockade of N OS results in the re ten tion  of this projection (W u et 
al., 1994). N O  is thus requ ired  for the refinem ent o f eye-specific 
projections from  the re tina  to  the optic tectum  in the chick. 
Interestingly, we show th a t in the retinogeniculate pathw ay o f the 
ferret, N O  is no t requ ired  for eye-specific layer refinem ent, bu t for 
a later, N M D A  recep to r-dependen t p a rt o f the pathw ay tha t 
segregates according to  on- o r off-center receptive field p ro p e r­
ties. Thus, although N O  has a role in the developm ent o f both the 
chick re tino tectal pathw ay and the fe rre t retinogeniculate p a th ­
way, the na tu re  of its role may differ, and these differences suggest 
th a t several different m echanism s are involved in activity- 
dependen t refinem ent o f the visual system.
A ctivity-dependent rem odeling of retinogeniculate connections 
during developm ent may resem ble activity-dependent synaptic 
plasticity in certain  regions o f the adu lt brain (C ram er and Sur, 
1995). In  particular, LTP in the CA1 region of the hippocam pus 
may share m echanism s in com m on with developm ental rem odel­
ing (G oodm an and Shatz, 1993). Postsynaptic activation of 
N M D A  receptors is requ ired  to  in itiate LTP (Bliss and Col- 
lingridge, 1993), w hereas m aintenance of LTP may require  pre- 
synaptic upregulation  o f neuro transm itter release (Bekkers and 
Stevens, 1990; M alinow and Tsien, 1990; M algaroli e t al., 1995).
8002 J. Neurosci., December 15, 1996, 16(24):7995-8004
Figure 8. Camera lucida tracings of representative P8 left and right LGN 
sections in a normal animal (A ), an animal treated with the NOS inhibitor 
L-NoArg (B), and an animal treated with the inactive isomer D-NAME 
(C). Drawings superimpose adjacent 40 or 50 am sections processed to 
reveal WGA-HRP after anterograde transport from the left eye or CTB 
subunit after transport from the right eye. In all cases, the labeling pattern 
is similarly complementary, consistent with normal eye-specific layer seg­
regation. Scale bar, 300 a m.
The developm ent of sublam inae in the LG N  represen ts an exam ­
ple of activity-dependent rem odeling of connections th a t may 
show m echanistic sim ilarities to  LTP in the hippocam pal CA1 
region. Sublam ination requires postsynaptic activation of N M D A  
receptors, which are presen t and involved in synaptic po ten tia tion  
in the developing L G N  (M ooney e t al., 1993). W hereas presyn- 
aptic N M D A  recep tors may be p resen t in visual cortex (Aoki et 
al., 1994), there  is no evidence for their p resence in the LGN. 
Physiological evidence suggests th a t N M D A  receptors are 
postsynaptic, because holding postsynaptic L G N  cells at hyperpo- 
larizing m em brane po tentials reduces the N M D A  com ponent of 
the postsynaptic cu rren t (E sguerra e t al., 1992; R am oa and M c­
Cormick, 1994). Additionally, the N M D A  antagonist d -APV  se­
lectively inhibits the N M D A  receptor-m ediated  com ponent of 
retinogeniculate EPSPs (E sguerra e t al., 1992). Presynaptic 
N M D A  recep tors w ould be expected to increase transm itter re ­
lease after C a2+  influx; thus blocking presynaptic receptors w ould 
influence all com ponents of the EPSP. By analogy w ith studies of 
LTP in the CA1 region of the hippocam pus, N O  m ay act down-
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Figure 9. Histogram summarizing the effect of NOS blockade on relative 
concentrations of arginine and citrulline in P8 and P28 ferret brain 
homogenates. The [arginine]/[citrulline] ratio significantly increased after 
application of L-NoArg (p  < 0.02, two-way ANOVA). Error bars indi­
cate SEM.
stream  of the N M D A  recep tor, diffusing to  the presynaptic te r ­
m inal to  transm it inform ation about postsynaptic activation. In  
LTP, this signal m ight result in increased  neuro transm itter release 
(Bekkers and Stevens, 1990; M alinow and Tsien, 1990; M algaroli 
e t al., 1995), w hereas in retinogeniculate developm ent, this signal 
m ay result in regulation  of presynaptic arbor size and position, 
because bo th  N M D A  recep to r blockade (H ahm  et al., 1991) and 
NOS blockade (in the p resen t study) result in inappropriately  
p laced retinogeniculate axon arbors. D eterm ination  of the extent 
of the similarity in the biochem ical m echanism s underlying 
activity-dependent refinem ent of connections and LTP will re ­
qu ire  additional investigation.
Possible substrates for N O  in the presynaptic term inal during 
LTP include guanylyl cyclase (E ast and G arthw aite, 1991), aden­
osine diphosphate ribosyl transferase (A D PR T ) (Schum an e t al.,
1994), or a com bination of bo th  (A be et al., 1994). It is no t known 
w hether e ither of these po ten tia l substrates has a role in devel­
opm ent or how they could induce changes in the size and position 
of afferent axon arbors. N O  is known to activate a cG M P-gated 
cation conductance in retinal ganglion cells via a NO-sensitive 
guanylyl cyclase (A hm ad e t al., 1994), resulting in an increase in 
in tracellu lar [Ca2+], which could in tu rn  regulate axonal structure 
(M attson and K ater, 1987). A  possible m ode of action w ith 
respect to  A D P R T  is tha t it acts on grow th-associated p ro te in  43 
(GAP-43; Coggins e t al., 1993; cf. Luo and V allano, 1995); this 
p ro te in  is expressed in growing axons during developm ent and 
regeneration  (Skene and W illard, 1981; M eiri e t al., 1988; M oya et 
al., 1988) and m ay have a role in rem odeling synaptic connections 
(E rzurum lu e t al., 1990; for review, see Benowitz and R outten- 
berg, 1987). A no ther possibility suggested by a study of cultured  
dorsal roo t ganglia (H ess et al., 1993) is tha t NO  inhibits growth 
cone elongation by inhibiting palm itoylation of pro teins such as 
GAP-43 and SNAP-25; this effect is independen t of guanylyl 
cyclase. A lthough the effect of N O  on p ro te in  palm itoylation in 
the developing ferre t L G N  is no t known, NO  may influence G APs 
via several different pathways.
A n alternative m echanism  for the action of N O  on developing 
retinogeniculate axons is re la ted  to  the role of N O  in regulating 
local b lood flow. A lthough our results suggest tha t increases in 
b lood  pressure after application of L-NoArg do no t account for
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the disruption of developm ent in the LG N , N O  is involved in the 
neuronal activity-dependent regulation o f local blood flow in the 
brain (for review, see Iadecola, 1993), and an inhibitor o f n eu ro ­
nal N OS decreases regional blood flow in the brain (Kelly e t al.,
1995). N O  produced  by N OS in response to  N M D A  recep tor 
activation m ight thus regulate the access o f presynaptic term inals 
to  circulating factors th a t are necessary for the contro l o f presyn- 
aptic structure.
A lthough N OS is presen t in a subset o f L G N  neurons, it is likely 
th a t the re trograde action of N O  is both  local and diffuse. NO 
might be released  from  L G N  neurons and influence synaptic 
stability in the retinal ganglion cell axons innervating them . In 
addition, N O  m ight diffuse to  nearby cells; a m echanism  for 
cooperative strengthening of nearby inputs has been dem on­
stra ted  in h ippocam pal LTP by Schum an and M adison (1994). 
M oreover, as described above, local increases in blood flow as a 
consequence of N O  release would influence a region th a t includes 
num erous synapses. Thus, N O  m ight have a local effect on a 
subset o f inputs to the L G N  and a m ore diffuse effect on a larger 
num ber o f inputs.
T he restriction o f retinogeniculate arbors into eye-specific lay­
ers and subsequently into O N /O FF  sublam inae involves the p ro ­
gressive elaboration  o f connections in appropriate  regions of the 
L G N  and the re traction  and loss o f connections from  inappropri­
ate regions. Blocking N M D A  recep tors causes no t only an in­
crease in the p roportion  of retinogeniculate arbors in the inap­
propria te  sublam ina bu t also a concom itant increase in the 
num ber and density o f postsynaptic dendritic  spines (R ocha and 
Sur, 1995). A lthough N O  is likely to  be produced  in the postsyn- 
aptic cell a fter activation of N M D A  receptors, it is available 
sim ultaneously to  both  presynaptic axons and postsynaptic cells. I t 
seem s reasonable to  propose th a t the coord inated  regulation of 
presynaptic and postsynaptic sites in the L G N  during sublam ina 
form ation is m ediated  by N O . O n this hypothesis, N M D A  recep­
tors and N O  provide a signal specifying correlated  inputs and 
coactive presynaptic and postsynaptic term inals. W hen N M D A  
receptors are active and N O  is presen t, contacts would stabilize; 
when N M D A  receptors o r N OS is blocked, contacts would con­
tinue to  tu rn  over and reorganize. T he presen t experim ents dem ­
onstrate  th a t blocking N OS indeed  prevents the restriction of 
retinogeniculate afferent arbors during an N M D A  receptor- 
dependen t phase o f developm ent; it would be of in terest to 
exam ine w hether blocking NOS leads to  an upregulation  o f spines 
on postsynaptic dendrites as well.
O ur results in the fe rre t L G N  contrast with studies o f cat visual 
cortex, in which ocular dom inance plasticity requires N M D A  
recep to r activation (B ear e t al., 1990) bu t does no t seem  to 
require  N O  (Gillespie e t al., 1993; D aw  e t al., 1994). C onsistent 
with this difference, N A D P H -d iap h o rase  staining is developm en­
tally regulated  in L G N  neurons bu t no t in visual cortical neurons. 
In  the cortex, staining is p resen t in a sm all subset o f cells at birth 
and a t every age exam ined through 6 postnatal weeks in the ferre t 
(C ram er e t al., 1995). M oreover, at 4 postnatal weeks, the density 
o f N A D P H -d iapho rase -labe led  cells in the L G N  is m uch higher 
than  th a t in the visual cortex.
Finally, ou r results, together with those of Sm etters e t al. 
(1994), suggest th a t the segregation of re tinal afferents into eye- 
specific layers p roceeds independently  of N O  o r N M D A  receptor 
activation and indicate th a t o th er activity-dependent m echanism s 
act during this phase. Interestingly, this dem onstrates th a t ra ther 
different m echanism s can be used  to  regulate sequential aspects of 
developm ent in the sam e pathway. N M D A  receptors and N O  are
well suited to  m ediate the la ter sharpening of connections into 
O N /O FF  sublam inae, which is accom panied by the m aturation  of 
photorecep tors and bipolar cells in the fe rre t re tina  and their 
functional connections to  re tina l ganglion cells (G reiner and 
W eidm an, 1981) (cf. Maslim and Stone, 1986). A dditionally, the 
distinct bu rst frequencies o f on and off re tina l ganglion cells 
becom e evident during this period  o f segregation (W ong and 
Oakley, 1996) and may thus establish patterns of correlated  ac­
tivity on which N M D A  receptors and N O  act to  shape the adult 
projection pattern .
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